Snapshot from Jul 07, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Companies / Eisai
Company

Eisai

Tracked across 7 events · 68 articles · First seen Apr 16, 2026 · Last active Jul 06, 2026

Sentiment
-16
Attention
6
Events
7
Relationships
10
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (7)
6 -80
Tech
Alzheimer's Anti-Amyloid Drugs Ineffective
Impact: Eisai co-produces lecanemab (Leqembi), an anti-amyloid drug whose effectiveness was disputed by the Cochrane review, potentially leading to financial repercussions.
Apr 16, 2026 · 6 articles
4 -30
International
Japanese Market Declines Amid Geopolitical Tensions
Impact: Eisai's stock tumbled and declined, contributing to the negative performance of some pharmaceutical companies.
May 18, 2026 · 23 articles
4 0
Business
Grey Matters receives PET scanner
Impact: Eisai, in collaboration with Biogen, developed Leqembi, one of the FDA-approved monoclonal antibody treatments for Alzheimer's Disease, which requires a positive beta-amyloid brain scan.
Jul 06, 2026 · 6 articles
4 0
Business
Eisai Projects Leqembi Revenue Growth
May 15, 2026 · 6 articles
2 0
Business
BioArctic Q1 2026 Report Presentation
May 13, 2026 · 7 articles
4 0
Regulatory
Leqembi Iqlik PDUFA Date Extended
May 08, 2026 · 14 articles
2 0
Business
BioArctic 2025 Annual Report Published
Apr 21, 2026 · 6 articles
Relationships (10)
BioArctic licensee ↔ Eisai Eisai holds the license to clinically develop and commercialize BioArctic's Alzh
BioArctic licensor ↔ Eisai BioArctic is the original developer and licensor of the Alzheimer's drug Leqembi
Biogen ↔ Eisai
Biogen ↔ Eisai
United States — Food and Drug Administration ↔ Eisai
United States — Food and Drug Administration ↔ Eisai
China ↔ Eisai
China ↔ Eisai
United States ↔ Eisai
United States ↔ Eisai
ERGEN INTELLIGENCE
Track Eisai live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.